Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Trudeau found in contempt of court

This article was originally published in The Tan Sheet

Executive Summary

The U.S. District Court for the Northern District of Illinois finds Kevin Trudeau in contempt for violating a 2004 permanent injunction by misrepresenting the contents of his book "The Weight Loss Cure 'They' Don't Want You to Know About," in infomercials, the Federal Trade Commission announces Nov. 21. The permanent injunction had prohibited Trudeau from misrepresenting the content of books, in addition to banning him from using infomercials to sell any products. The court ruled Trudeau "misled thousands of consumers" with a diet protocol he touted as "easy," but actually involved extreme dieting, daily injections and lifelong dietary restrictions. FTC filed a brief in September asking the court to find Trudeau in contempt (1"The Tan Sheet" Sept. 17, 2007, In Brief)...

You may also be interested in...

Contempt charge “they” want you to know about

The Federal Trade Commission alleges author and infomercial personality Kevin Trudeau violated a court order issued as part of a 2004 settlement by making false representations about the weight-loss plan outlined in his book "The Weight Loss Cure 'They' Don't Want You to Know About." The 2004 order, which settled charges of false claims related to coral calcium and other products, banned Trudeau from using infomercials to sell any product service or program (1"The Tan Sheet" Sept. 13, 2004, In Brief). However, it allowed a narrow exemption for promoting books, provided he "not misrepresent the content of the books," FTC notes. In an infomercial, Trudeau called the book's weight-loss regimen "easy," and said when it is completed one can "eat whatever you want and you don't gain the weight back," the commission says. According to FTC, consumers buying the book "find it actually describes a complicated, expensive system involving daily injections, specialized cleanses and supplements, and severe food restrictions, followed by a 'fourth phase' of the protocol, which requires dietary restrictions and never ends." FTC's Sept. 13 brief filed in the U.S. District Court for the Northern District of Illinois asks for Trudeau to be found in contempt and ordered to pay consumer redress...

The ICER Process: Allergan Engagement Improves Cost Effectiveness Rating For Ubrelvy

ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.

US FDA’s 2020 Approvals: A Deep Pipeline, And More Of The Expected

Almost 50 novel agents are already under review at FDA for potential 2020 approval. Candidates are notably diverse, with concentrations in established strongholds (oncology, neuroscience), popular programs (breakthrough), and powerhouse sponsors (keep an eye on Bristol-Myers Squibb right out of the gate).





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts